Inari Medical

$69.28 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Inari Medical

Inari Medical, Inc. is a commercial-stage medical device company. The Company is focused on developing products to treat venous diseases. The Company’s product offering consists of two minimally-invasive, catheter-based mechanical thrombectomy devices. The Company built two products for the treatment of venous thromboembolism (VTE deep vein thrombosis) and pulmonary embolism (PE). The Company provides two products ClotTriever and FlowTriever. ClotTriever product is Food and Drug Administration (FDA) cleared for the removal of clot from peripheral blood vessels and is used to deep vein thrombosis (DVT). FlowTriever product is thrombectomy system FDA cleared for the treatment of pulmonary embolism (PE). Its product ClotTriever and FlowTriever offer clinical benefits and provides safety to limit effectiveness of thrombolytic drugs and repurposed arterial devices for the treatment of VTE.

Stock Analysis

last close $69.36
1-mo return 2.7%
3-mo return -23.1%
avg daily vol. 658.85T
52-week high 100
52-week low 50.5
market cap. $3.8B
forward pe -
annual div. -
roe -0.24%
ltg forecast 44.7%
dividend yield -
annual rev. $306M
inst own. 85.2%

Subscribe now for daily local and international financial news